Rask Invest Research Team

The Rask Invest research team produces daily ASX news and research on ASX-listed companies and funds. Join the conversation inside the free investor community. Click here to have your say.

99% of long-term investing is doing nothing; the other 1% changes your life

Rask Invest Research Team's latest insights

Today's ASX news

A deep dive into RMD shares

Is the Resmed CDI (ASX:RMD) share price undervalued? Here are 3 reasons you might want to consider RMD shares.

Today's ASX news

COH shares: your next growth investment?

The Cochlear Ltd (ASX:COH) share price is down 9.4% since the start of 2025. It’s probably worth asking, ‘is the COH share price undervalued?’

Today's ASX news

An easy way to value A2M and WOW shares

The A2 Milk Company Ltd (ASX:A2M) share price has risen 43.4% since the start of 2025. It’s probably worth asking, ‘is the A2M share price top value?’

ASX Bank Shares

4 best numbers to value CBA shares

Trying to value the Commonwealth Bank of Australia (ASX:CBA) share price? Here are 4 key metrics you need to consider.

Better investing starts here.

Want to level-up your analytical skills and investing insights but don’t know where to start? Join 50,000 Australian investors on our mailing list and we’ll send you our favourite podcasts, courses, resources and investment articles every Sunday morning. Grab a coffee and let Owen and the team bring you the best  insights.

Here you go: A $50,000 per year passive income special report

Join more 50,000 Australian investors who read our weekly investing newsletter and we’ll send you our passive income investing report right now.

Simply enter your email address and we’ll send it to you. No tricks. Unsubscribe anytime.

Unsubscribe anytime. Read our TermsFinancial Services GuidePrivacy Policy. We’ll never sell your email address. Our company is Australian owned.